Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGNDZ) Non-Current Assets (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Non-Current Assets for 16 consecutive years, with $728.4 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 19.36% to $728.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 billion through Dec 2025, up 12.24% year-over-year, with the annual reading at $728.4 million for FY2025, 19.36% up from the prior year.
  • Non-Current Assets hit $728.4 million in Q4 2025 for Ligand Pharmaceuticals, up from $722.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $857.7 million in Q1 2021 to a low of $481.4 million in Q2 2023.
  • Historically, Non-Current Assets has averaged $669.8 million across 5 years, with a median of $627.8 million in 2024.
  • Biggest five-year swings in Non-Current Assets: skyrocketed 141.47% in 2021 and later tumbled 42.18% in 2023.
  • Year by year, Non-Current Assets stood at $832.8 million in 2021, then crashed by 40.08% to $499.1 million in 2022, then rose by 10.16% to $549.8 million in 2023, then rose by 10.99% to $610.2 million in 2024, then increased by 19.36% to $728.4 million in 2025.
  • Business Quant data shows Non-Current Assets for LGNDZ at $728.4 million in Q4 2025, $722.9 million in Q3 2025, and $595.7 million in Q2 2025.